- Home
- Publications
- Publication Search
- Publication Details
Title
Current Status of Molecular Biomarkers in Endometrial Cancer
Authors
Keywords
Endometrial cancer, Molecular biomarkers, Prognostic biomarkers, Predictive biomarkers, Biomarker validation, Clinical utility, Gynaecologic cancer
Journal
Current Oncology Reports
Volume 16, Issue 9, Pages -
Publisher
Springer Nature
Online
2014-07-26
DOI
10.1007/s11912-014-0403-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer
- (2014) D. R. Parkinson et al. CLINICAL CANCER RESEARCH
- Clinical value of DNA content assessment in endometrial cancer
- (2014) Karen Klepsland Mauland et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- The Search Continues
- (2014) Larissa A. Meyer et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cancer Systems Biology: a peek into the future of patient care?
- (2014) Henrica M. J. Werner et al. Nature Reviews Clinical Oncology
- Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
- (2014) Henrica M. J. Werner et al. PLoS One
- HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
- (2013) Sofie L. Antonsen et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas
- (2013) I S Haldorsen et al. BRITISH JOURNAL OF CANCER
- Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer
- (2013) Yoshimichi Tanaka et al. CANCER BIOLOGY & THERAPY
- Lack of Estrogen Receptor- Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- Companion Biomarkers: Paving the Pathway to Personalized Treatment for Cancer
- (2013) M. J. Duffy et al. CLINICAL CHEMISTRY
- Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
- (2013) Jone Trovik et al. EUROPEAN JOURNAL OF CANCER
- Sentinel lymph node mapping with pathologic ultrastaging: A valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion
- (2013) Christine H. Kim et al. GYNECOLOGIC ONCOLOGY
- Serum HE4 as a prognostic marker in endometrial cancer — A population based study
- (2013) Donal J. Brennan et al. GYNECOLOGIC ONCOLOGY
- Designing Transformative Clinical Trials in the Cancer Genome Era
- (2013) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Implementing personalized cancer genomics in clinical trials
- (2013) Richard Simon et al. NATURE REVIEWS DRUG DISCOVERY
- Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review
- (2013) H.M.P. Pelikan et al. CANCER IMAGING
- Clinicopathologic Analysis of Matched Primary and Recurrent Endometrial Carcinoma
- (2012) Robert A. Soslow et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
- (2012) C Krakstad et al. BRITISH JOURNAL OF CANCER
- KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
- (2012) E Birkeland et al. BRITISH JOURNAL OF CANCER
- Intratumor Heterogeneity: Evolution through Space and Time
- (2012) C. Swanton CANCER RESEARCH
- Development and Use of Integral Assays in Clinical Trials
- (2012) R. L. Schilsky et al. CLINICAL CANCER RESEARCH
- High EGFR Gene Copy Number and Skin Rash as Predictive Markers for EGFR Tyrosine Kinase Inhibitors in Patients with Advanced Squamous Cell Lung Carcinoma
- (2012) Y. Lee et al. CLINICAL CANCER RESEARCH
- Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
- (2012) Laura Zanotti et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation
- (2012) Remi A. Nout et al. GYNECOLOGIC ONCOLOGY
- Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas
- (2012) Ingfrid S. Haldorsen et al. GYNECOLOGIC ONCOLOGY
- HE4 is an independent prognostic marker in endometrial cancer patients
- (2012) Irene Mutz-Dehbalaie et al. GYNECOLOGIC ONCOLOGY
- Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective
- (2012) Jone Trovik et al. GYNECOLOGIC ONCOLOGY
- MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer — A multicenter prospective comparative study
- (2012) Sofie Leisby Antonsen et al. GYNECOLOGIC ONCOLOGY
- Molecular pathology of endometrial carcinoma
- (2012) Xavier Matias-Guiu et al. HISTOPATHOLOGY
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations
- (2012) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
- (2012) Linda Sofie Lindström et al. JOURNAL OF CLINICAL ONCOLOGY
- Contemporary management of endometrial cancer
- (2012) Jason D Wright et al. LANCET
- Markers for individualised therapy in endometrial carcinoma
- (2012) Helga B Salvesen et al. LANCET ONCOLOGY
- ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
- (2012) Henrica M J Werner et al. MODERN PATHOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
- (2012) Sara A. Byron et al. PLoS One
- DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
- (2012) Manohar Pradhan et al. VIRCHOWS ARCHIV
- Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment
- (2012) Oluwole Fadare et al. Journal of Cancer
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- (2011) Eitan Amir et al. CANCER TREATMENT REVIEWS
- Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer
- (2011) J. Trovik et al. CLINICAL CANCER RESEARCH
- Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer
- (2011) A. C. Staff et al. CLINICAL CANCER RESEARCH
- Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques
- (2011) I.S. Haldorsen et al. CLINICAL RADIOLOGY
- Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer
- (2011) Erica Ambeba et al. Future Oncology
- The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
- (2011) James Nicklin et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
- (2011) John P. A. Ioannidis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
- (2011) Kimberly C Wiegand et al. JOURNAL OF PATHOLOGY
- Trends in Endometrial Cancer Incidence Rates in the United States, 1999–2006
- (2011) Linh M. Duong et al. JOURNAL OF WOMENS HEALTH
- Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma
- (2011) Anita Steinbakk et al. MODERN PATHOLOGY
- Emerging therapeutic targets in endometrial cancer
- (2011) Konstantin J. Dedes et al. Nature Reviews Clinical Oncology
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- Para-aortic Lymphadenectomy in the Management of Preoperative Grade 1 Endometrial Cancer Confined to the Uterine Corpus
- (2010) Jong-Hyuck Yoon et al. ANNALS OF SURGICAL ONCOLOGY
- Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
- (2010) Marcos Ballester et al. BMC CANCER
- Prognostic Value of E-Cadherin Expression and CDH1 Promoter Methylation in Patients With Endometrial Carcinoma
- (2010) Tie-Zhong Yi et al. CANCER INVESTIGATION
- Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
- (2010) J. E. Dancey et al. CLINICAL CANCER RESEARCH
- Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature
- (2010) Cagatay Arslan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Three-dimensional ultrasound for assessing women with gynecological cancer: A systematic review
- (2010) Juan Luis Alcázar et al. GYNECOLOGIC ONCOLOGY
- Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer
- (2010) Jone Trovik et al. HISTOPATHOLOGY
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury?
- (2010) Mustafa Khasraw et al. Current Oncology Reports
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- Systemic therapy for recurrent endometrial cancer: a review of North American trials
- (2009) Thanh H Dellinger et al. Expert Review of Anticancer Therapy
- Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
- (2009) Nadeem R. Abu-Rustum et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- (2009) Sergio Pecorelli INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Concomitant PI3K–AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis
- (2009) Lluis Catasus et al. MODERN PATHOLOGY
- p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
- (2009) Karuna Garg et al. MODERN PATHOLOGY
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
- (2009) H. B. Salvesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
- (2008) Ingeborg B. Engelsen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Aneuploidy Predicts Outcome in Patients with Endometrial Carcinoma and Is Related to Lack of CDH13 Hypermethylation
- (2008) Y. Suehiro et al. CLINICAL CANCER RESEARCH
- Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- (2008) Vincent Jongen et al. GYNECOLOGIC ONCOLOGY
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
- (2008) P. B. Panici et al. JNCI-Journal of the National Cancer Institute
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
- (2008) LANCET
- Drug-sensitive FGFR2 mutations in endometrial carcinoma
- (2008) A. Dutt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started